XTL Biopharmaceuticals Statistics
Total Valuation
XTLB has a market cap or net worth of $10.89 million. The enterprise value is $9.17 million.
Important Dates
The next estimated earnings date is Monday, May 19, 2025, before market open.
| Earnings Date | May 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XTLB has 881.39 million shares outstanding. The number of shares has increased by 7.97% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 881.39M |
| Shares Change (YoY) | +7.97% |
| Shares Change (QoQ) | +31.89% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 749.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 236.71 |
| Forward PS | n/a |
| PB Ratio | 1.90 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 199.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.81
| Current Ratio | 0.81 |
| Quick Ratio | 0.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42.16 |
Financial Efficiency
Return on equity (ROE) is -25.70% and return on invested capital (ROIC) is -23.73%.
| Return on Equity (ROE) | -25.70% |
| Return on Assets (ROA) | -16.33% |
| Return on Invested Capital (ROIC) | -23.73% |
| Return on Capital Employed (ROCE) | -22.90% |
| Revenue Per Employee | $6,571 |
| Profits Per Employee | -$150,857 |
| Employee Count | 7 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.52% in the last 52 weeks. The beta is 1.07, so XTLB's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | -55.52% |
| 50-Day Moving Average | 1.44 |
| 200-Day Moving Average | 2.03 |
| Relative Strength Index (RSI) | 47.72 |
| Average Volume (20 Days) | 4,820 |
Short Selling Information
The latest short interest is 56,279, so 0.75% of the outstanding shares have been sold short.
| Short Interest | 56,279 |
| Short Previous Month | 68,071 |
| Short % of Shares Out | 0.75% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.31 |
Income Statement
In the last 12 months, XTLB had revenue of $46,000 and -$1.06 million in losses. Loss per share was -$0.00.
| Revenue | 46,000 |
| Gross Profit | 46,000 |
| Operating Income | -1.56M |
| Pretax Income | n/a |
| Net Income | -1.06M |
| EBITDA | n/a |
| EBIT | -1.56M |
| Loss Per Share | -$0.00 |
Full Income StatementBalance Sheet
The company has $1.72 million in cash and n/a in debt, giving a net cash position of $1.72 million or $0.00 per share.
| Cash & Cash Equivalents | 1.72M |
| Total Debt | n/a |
| Net Cash | 1.72M |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | 5.72M |
| Book Value Per Share | 0.01 |
| Working Capital | -480,000 |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -3,391.30% |
| Pretax Margin | -2,295.65% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |